| Mutations in PLOD3, encoding lysyl hydroxylase 3, cause a complex connective tissue disorder including recessive dystrophic epidermolysis bullosa-like blistering phenotype with … H Vahidnezhad, L Youssefian, AH Saeidian, A Touati, S Pajouhanfar, ... Matrix Biology 81, 91-106, 2019 | 48 | 2019 |
| Multigene next-generation sequencing panel identifies pathogenic variants in patients with unknown subtype of epidermolysis bullosa: subclassification with prognostic implications H Vahidnezhad, L Youssefian, AH Saeidian, A Touati, S Sotoudeh, ... Journal of Investigative Dermatology 137 (12), 2649-2652, 2017 | 41 | 2017 |
| Influence of glutathione S‐transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response G Rostami, D Assad, F Ghadyani, M Hamid, A Karami, H Jalaeikhoo, ... Molecular Genetics & Genomic Medicine 7 (7), e00717, 2019 | 30 | 2019 |
| A novel 355-357delGAG mutation and frequency of connexin-26 (GJB2) mutations in Iranian patients M Hamid, M Karimipoor, MH Chaleshtori, MT Akbari Journal of Genetics 88 (3), 359, 2009 | 29 | 2009 |
| Genome‐wide single nucleotide polymorphism‐based autozygosity mapping facilitates identification of mutations in consanguineous families with epidermolysis bullosa H Vahidnezhad, L Youssefian, AH Saeidian, S Zeinali, A Touati, M Abiri, ... Experimental Dermatology 28 (10), 1118-1121, 2019 | 28 | 2019 |
| Identification of α-globin chain variants: A report from Iran MT Akbari, M Hamid ARCHIVES OF IRANIAN MEDICINE 15 (9), 564-567, 2012 | 21 | 2012 |
| Molecular characterization of β-thalassemia intermedia: a report from Iran A Arab, M Karimipoor, A Rajabi, M Hamid, S Arjmandi, S Zeinali Molecular biology reports 38, 4321-4326, 2011 | 21 | 2011 |
| Molecular analysis of γ-globin promoters, HS-111 and 3′ HS1, in β-thalassemia intermedia patients associated with high levels of Hb F M Hamid, F Mahjoubi, MT Akbari, A Arab, S Zeinali, M Karimipoor Hemoglobin 33 (6), 428-438, 2009 | 20 | 2009 |
| Genetic mutations and immunological features of severe combined immunodeficiency patients in Iran Z Shahbazi, R Yazdani, S Shahkarami, S Shahbazi, M Hamid, ... Immunology letters 216, 70-78, 2019 | 19 | 2019 |
| The relationship between matrix metalloproteinase gene polymorphisms and tumor type, tumor size, and metastasis in women with breast cancer in Central Iran Z Dehghan Manshadi, M Hamid, F Kosari, H Tayebinia, I Khodadadi Middle East Journal of Cancer 9 (2), 123-131, 2018 | 18 | 2018 |
| Impact of the BCR-ABL1 fusion transcripts on different responses to Imatinib and disease recurrence in Iranian patients with Chronic Myeloid Leukemia G Rostami, M Hamid, H Jalaeikhoo Gene 627, 202-206, 2017 | 16 | 2017 |
| Incidence and clinical importance of BCR-ABL1 mutations in Iranian patients with chronic myeloid leukemia on imatinib G Rostami, M Hamid, M Yaran, M Khani, M Karimipoor Journal of human genetics 60 (5), 253-258, 2015 | 12 | 2015 |
| Wolf-Hirschhorn syndrome: a case with normal karyotype, demonstrated by array CGH (aCGH) A Saberi, G Shariati, M Hamid, H Galehdari, N Abdorasouli Archives of Iranian Medicine 17 (9), 0-0, 2014 | 12 | 2014 |
| Gene expression in blood from an individual with β‐thalassemia: An RNA sequence analysis F Taghavifar, M Hamid, G Shariati Molecular genetics & genomic medicine 7 (7), e00740, 2019 | 11 | 2019 |
| Multidrug-resistant strains of Mycobacterium tuberculosis isolated from patients in Tehran belong to a genetically distinct cluster MM Feizabadi, M Shahriari, M Safavi, S Gharavi, M Hamid Scandinavian journal of infectious diseases 35 (1), 47-51, 2003 | 11 | 2003 |
| Alpha‐globin gene triplication and its effect in beta‐thalassemia carrier, sickle cell trait, and healthy individual M Hamid, B Keikhaei, H Galehdari, A Saberi, A Sedaghat, G Shariati, ... EJHaem 2 (3), 366-374, 2021 | 9 | 2021 |
| Clinical features, DYT1 mutation screening and genotype-phenotype correlation in patients with dystonia from Iran MT Akbari, Z Zand, GA Shahidi, M Hamid Medical Principles and Practice 21 (5), 462-466, 2012 | 9 | 2012 |
| The intrinsic genetic and epigenetic regulator factors as therapeutic targets, and the effect on fetal globin gene expression P Adelvand, M Hamid, S Sardari Expert Review of Hematology 11 (1), 71-81, 2018 | 8 | 2018 |
| A 13-bp deletion in the 3′ untranslated region of the β-globin gene causes β-thalassemia major in compound heterozygosity with IVSII-1 mutation M Hamid, MT Akbari Medical principles and practice 20 (5), 488-490, 2011 | 8 | 2011 |
| The Frequency of BCR-ABL1 Fusion Transcripts in Iranian Patients with Three Different Types of Leukemia M Hamid, H Bokharaei Zahedan Journal of Research in Medical Sciences 19 (7), 2017 | 7 | 2017 |
Alihossein SaberiAhvaz Jundishapur Univesity of Medical Sciences在 ajums.ac.ir 的电子邮件经过验证
